Cyclopentolate
Back to searchMolecule Structure
Scientific Name
Cyclopentolate
Description of the Drug
Cyclopentolate is an anticholinergic used to cause mydriasis and cycloplegia for diagnostic testing.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00979
http://www.drugbank.ca/drugs/DB00979
Brand Name(s)
Not Available
Company Owner(s)
Sola Barnes Hind, Bausch And Lomb Pharmaceuticals Inc, Alcon Pharmaceuticals Ltd, Pharmafair Inc, Alcon Laboratories Inc, Akorn Operating Co Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Muscarinic acetylcholine receptor M3 | SINGLE PROTEIN | ANTAGONIST | CHEMBL245 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL132500 | ||
PharmGKB | PA164743019 | ||
Human Metabolome Database | HMDB0015114 | ||
DrugBank | DB00979 | ||
PubChem: Thomson Pharma | 15270905 | ||
PubChem | 2905 | ||
LINCS | LSM-1800 | ||
Nikkaji | J264.904G | J6.274J | J264.905E |
BindingDB | 82375 | ||
EPA CompTox Dashboard | DTXSID3048528 | ||
DrugCentral | 757 | ||
ChemicalBook | CB9707085 | ||
Guide to Pharmacology | 7153 | ||
rxnorm | CYCLOPENTOLATE | CYCLOPENTOLATE HYDROCHLORIDE | CYCLOGYL |
KEGG Ligand | C06932 | ||
ChEBI | 4024 |